Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults
Children's Hospital Medical Center, Cincinnati
Children's Hospital Medical Center, Cincinnati
University of Heidelberg Medical Center
M.D. Anderson Cancer Center
Pfizer
Werewolf Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Janssen Research & Development, LLC
University of California, San Diego
Wake Forest University Health Sciences
AbbVie
UNC Lineberger Comprehensive Cancer Center
Gazi University
University of California, San Diego
BeiGene
Arab American University (Palestine)
Washington University School of Medicine
Cytosite Biopharma Inc.
Akdeniz University
Hospices Civils de Lyon
National Institutes of Health Clinical Center (CC)
Trishula Therapeutics, Inc.
AbbVie
University of Colorado, Denver
Thomas Jefferson University
National Cancer Centre, Singapore
Intensity Therapeutics, Inc.
Juno Therapeutics, a Subsidiary of Celgene
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
BPGbio
Ann & Robert H Lurie Children's Hospital of Chicago
Janssen Research & Development, LLC
The Lymphoma Academic Research Organisation
Cyteir Therapeutics, Inc.
EpicentRx, Inc.
Calibr, a division of Scripps Research
National Cancer Institute (NCI)
AbbVie
Astex Pharmaceuticals, Inc.
Kyowa Kirin Co., Ltd.
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Amgen
Cedars-Sinai Medical Center
University of Ulm
Constellation Pharmaceuticals
Kyowa Kirin Co., Ltd.
British Columbia Cancer Agency
Virginia Commonwealth University